Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

BACKGROUND: The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2) positive advanced/metastatic gastric or gastroesophageal junction cancer. ToGA showed that trastuzumab plus chemotherapy (capecitabine...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sawaki, Akira, Ohashi, Yasuo, Omuro, Yasushi, Satoh, Taroh, Hamamoto, Yasuo, Boku, Narikazu, Miyata, Yoshinori, Takiuchi, Hiroya, Yamaguchi, Kensei, Sasaki, Yasutsuna, Nishina, Tomohiro, Satoh, Atsushi, Baba, Eishi, Tamura, Takao, Abe, Takashi, Hatake, Kiyohiko, Ohtsu, Atsushi
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3390686/
https://ncbi.nlm.nih.gov/pubmed/22179434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-011-0118-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars